Clinical Trial Update: Evaluation of Drug Resistance in Patients With Metastatic Breast Cancer [Phase 2]

View source ↗

Summary

This Phase 2 clinical trial update concerns evaluating drug resistance in metastatic breast cancer; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Oncotech | Conditions: Breast Cancer | Phase 2 | Status: UNKNOWN